Chugai Pharmaceutical Co stock forecast
Chugai Pharmaceutical Co (4519N) Stock Forecast & Price Target
4519N Analyst Ratings
4519N Stock 12 Month Forecast
Average Price Target
Mex$943.95▲(26.94% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Citi | Mex$1,289→Mex$1,277 | buy | 71.75%Upside | Reiterated | 10/29/26 | |||
| Morgan Stanley | Mex$969.49 | buy | 30.37%Upside | Reiterated | 10/28/26 | |||
| Asad Haider | Goldman Sachs | Mex$1,016 | buy | 36.62%Upside | Reiterated | 10/20/26 | ||
| Macquarie | Mex$882.41→Mex$847.58 | buy | 13.98%Upside | Reiterated | 10/16/26 | |||
| UBS | Mex$835.97→Mex$777.92 | hold | 4.61%Upside | Reiterated | 10/14/26 | |||
| Stephen Barker | Jefferies | Mex$928.86→Mex$708.25 | hold | -4.76%Downside | Reiterated | 09/29/26 | ||
| Daiwa | Mex$1,033 | buy | 38.96%Upside | Reiterated | 09/28/26 | |||
| SBI Securities | Mex$1,103 | buy | 48.33%Upside | Reiterated | 09/09/26 | |||
| Nomura | Mex$928.86→Mex$882.41 | hold | 18.66%Upside | Reiterated | 09/01/26 | |||
| Mizuho Securities | Mex$957.88→Mex$824.36 | hold | 10.86%Upside | Reiterated | 08/19/26 | |||
| Bank of America Securities | Mex$1,022→Mex$870.80 | hold | 17.10%Upside | Reiterated | 08/14/26 | |||
| Miki Sogi | Bernstein | Mex$1,138 | buy | 53.01%Upside | Reiterated | 07/07/26 | ||
| J.P. Morgan | Mex$1,277 | buy | 71.75%Upside | Reiterated | 05/27/26 | |||
| SMBC Nikko | Mex$1,103→Mex$1,242 | buy | 67.06%Upside | Reiterated | 02/25/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| BuyReiteratedMex$1,289→Mex$1,277 | 10/29/26 | 71.75%Upside | |||
| BuyReiteratedMex$969.49 | 10/28/26 | 30.37%Upside | |||
| Asad HaiderGoldman Sachs | BuyReiteratedMex$1,016 | 10/20/26 | 36.62%Upside | ||
| BuyReiteratedMex$882.41→Mex$847.58 | 10/16/26 | 13.98%Upside | |||
| HoldReiteratedMex$835.97→Mex$777.92 | 10/14/26 | 4.61%Upside | |||
| Stephen BarkerJefferies | HoldReiteratedMex$928.86→Mex$708.25 | 09/29/26 | -4.76%Downside | ||
| BuyReiteratedMex$1,033 | 09/28/26 | 38.96%Upside | |||
| BuyReiteratedMex$1,103 | 09/09/26 | 48.33%Upside | |||
| HoldReiteratedMex$928.86→Mex$882.41 | 09/01/26 | 18.66%Upside | |||
| HoldReiteratedMex$957.88→Mex$824.36 | 08/19/26 | 10.86%Upside | |||
| HoldReiteratedMex$1,022→Mex$870.80 | 08/14/26 | 17.10%Upside | |||
| Miki SogiBernstein | BuyReiteratedMex$1,138 | 07/07/26 | 53.01%Upside | ||
| BuyReiteratedMex$1,277 | 05/27/26 | 71.75%Upside | |||
| BuyReiteratedMex$1,103→Mex$1,242 | 02/25/26 | 67.06%Upside |
Best Analysts Covering Chugai Pharmaceutical Co
Copying Seiji Wakao's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.65% per trade.
Copying Tony Ren's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -3.70% per trade.
Copying Seiji Wakao's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.20% per trade.
4519N Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 |
| Buy | 6 | 5 | 7 | 6 | 6 |
| Hold | 5 | 5 | 6 | 6 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 12 | 11 | 14 | 14 | 11 |
In the current month, 4519N has received 8 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 4519N average Analyst price target in the past 3 months is 943.95.
4519N Financial Forecast
4519N Earnings Forecast
Next quarter’s earnings estimate for 4519N is MXN 9.30 with a range of MXN 8.13 to MXN 10.07. The previous quarter’s EPS was MXN 11.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
4519N Sales Forecast
Next quarter’s sales forecast for 4519N is MXN 40.01B with a range of MXN 34.49B to MXN 45.15B. The previous quarter’s sales results were MXN 48.35B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

